EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy

Detalles Bibliográficos
Autores principales: Kim, Minhye, Na, Ji Min, Lee, Gyeong-Won, Lee, Seung Jun, Kim, Jong Duk, Yang, Jung Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Materias:
Brief Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829570/
https://www.ncbi.nlm.nih.gov/pubmed/33260286
http://dx.doi.org/10.4132/jptm.2020.11.02

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829570/
https://www.ncbi.nlm.nih.gov/pubmed/33260286
http://dx.doi.org/10.4132/jptm.2020.11.02

Ejemplares similares